BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27084312)

  • 1. Dysregulation of WNT5A/ROR2 Signaling Characterizes the Progression of Barrett-Associated Esophageal Adenocarcinoma.
    Lyros O; Nie L; Moore T; Medda R; Otterson M; Behmaram B; Mackinnon A; Gockel I; Shaker R; Rafiee P
    Mol Cancer Res; 2016 Jul; 14(7):647-59. PubMed ID: 27084312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical roles of Wnt5a-Ror2 signaling in aggressiveness of tongue squamous cell carcinoma and production of matrix metalloproteinase-2 via ΔNp63β-mediated epithelial-mesenchymal transition.
    Sakamoto T; Kawano S; Matsubara R; Goto Y; Jinno T; Maruse Y; Kaneko N; Hashiguchi Y; Hattori T; Tanaka S; Kitamura R; Kiyoshima T; Nakamura S
    Oral Oncol; 2017 Jun; 69():15-25. PubMed ID: 28559016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt5a suppresses osteoblastic differentiation of human periodontal ligament stem cell-like cells via Ror2/JNK signaling.
    Hasegawa D; Wada N; Yoshida S; Mitarai H; Arima M; Tomokiyo A; Hamano S; Sugii H; Maeda H
    J Cell Physiol; 2018 Feb; 233(2):1752-1762. PubMed ID: 28681925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
    Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
    Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt5a and Ror2 expression associate with the disease progress of primary thyroid lymphoma.
    Wang L; Yang D; Wang YH; Li X; Gao HM; Lv JY; Wang L; Xin SJ
    Tumour Biol; 2016 May; 37(5):6085-90. PubMed ID: 26608372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. circPVT1 promotes osteosarcoma glycolysis and metastasis by sponging miR-423-5p to activate Wnt5a/Ror2 signaling.
    Wan J; Liu Y; Long F; Tian J; Zhang C
    Cancer Sci; 2021 May; 112(5):1707-1722. PubMed ID: 33369809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
    Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N
    Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The WNT5A/ROR2 signaling pathway in pancreatic ductal adenocarcinoma (PDAC).
    Remtisch L; Wiltberger G; Schierle K; Yousef M; Thieme R; Jansen Winkeln B; Wittekind C; Gockel I; Lyros O
    J BUON; 2021; 26(4):1595-1606. PubMed ID: 34565024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse regulation of mammary epithelial growth and branching morphogenesis through noncanonical Wnt signaling.
    Kessenbrock K; Smith P; Steenbeek SC; Pervolarakis N; Kumar R; Minami Y; Goga A; Hinck L; Werb Z
    Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3121-3126. PubMed ID: 28270600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of Ror2 suppresses TNF‑α‑induced inflammation and apoptosis in vascular endothelial cells.
    Yang X; Zhao S; Yuan H; Shi R; Gu W; Gu Z; Lu X; Zhao H
    Mol Med Rep; 2020 Oct; 22(4):2981-2989. PubMed ID: 32945438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt5a/Ror2 pathway contributes to the regulation of cholesterol homeostasis and inflammatory response in atherosclerosis.
    Zhang CJ; Zhu N; Liu Z; Shi Z; Long J; Zu XY; Tang ZW; Hu ZY; Liao DF; Qin L
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158547. PubMed ID: 31678514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis.
    Maeda K; Kobayashi Y; Udagawa N; Uehara S; Ishihara A; Mizoguchi T; Kikuchi Y; Takada I; Kato S; Kani S; Nishita M; Marumo K; Martin TJ; Minami Y; Takahashi N
    Nat Med; 2012 Feb; 18(3):405-12. PubMed ID: 22344299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WNT5a Signaling through ROR2 Activates the Hippo Pathway to Suppress YAP1 Activity and Tumor Growth.
    Wang K; Ma F; Arai S; Wang Y; Varkaris A; Poluben L; Voznesensky O; Xie F; Zhang X; Yuan X; Balk SP
    Cancer Res; 2023 Apr; 83(7):1016-1030. PubMed ID: 36622276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal Wnt5a Plays a Key Role in Spinal Dendritic Spine Remodeling in Neuropathic and Inflammatory Pain Models and in the Proalgesic Effects of Peripheral Wnt3a.
    Simonetti M; Kuner R
    J Neurosci; 2020 Aug; 40(35):6664-6677. PubMed ID: 32616667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis.
    Geng M; Cao YC; Chen YJ; Jiang H; Bi LQ; Liu XH
    World J Gastroenterol; 2012 Mar; 18(12):1328-38. PubMed ID: 22493546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt5A regulates the expression of ROR2 tyrosine kinase receptor in ovarian cancer cells.
    Hossein G; Arabzadeh S; Salehi-Dulabi Z; Dehghani-Ghobadi Z; Heidarian Y; Talebi-Juybari M
    Biochem Cell Biol; 2017 Dec; 95(6):609-615. PubMed ID: 28538104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt5a/Ror2 promotes vascular smooth muscle cells proliferation via activating PKC.
    Shi Y; Li H; Gu J; Gong Y; Xie X; Liao D; Qin L
    Folia Histochem Cytobiol; 2022; 60(3):271-279. PubMed ID: 36177743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt5a-Ror2 signaling in mesenchymal stem cells promotes proliferation of gastric cancer cells by activating CXCL16-CXCR6 axis.
    Takiguchi G; Nishita M; Kurita K; Kakeji Y; Minami Y
    Cancer Sci; 2016 Mar; 107(3):290-7. PubMed ID: 26708384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
    Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y
    Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation.
    Yu J; Chen L; Cui B; Widhopf GF; Shen Z; Wu R; Zhang L; Zhang S; Briggs SP; Kipps TJ
    J Clin Invest; 2016 Feb; 126(2):585-98. PubMed ID: 26690702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.